相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The clinical relevance of gene expression based prognostic signatures in colorectal cancer
Pankaj Ahluwalia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Ferroptosis: molecular mechanisms and health implications
Daolin Tang et al.
CELL RESEARCH (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
MiR-454-3p Promotes Oxaliplatin Resistance by Targeting PTEN in Colorectal Cancer
Xiao-Lan Qian et al.
FRONTIERS IN ONCOLOGY (2021)
Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells
Xuan Deng et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin
Xuefei Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer
Tzu-Tang Wei et al.
ONCOGENE (2020)
Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer
Zengyao Li et al.
CARCINOGENESIS (2020)
Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Jaume Capdevila et al.
CLINICAL CANCER RESEARCH (2020)
LncRNA-cCSC1 modulates cancer stem cell properties in colorectal cancer via activation of the Hedgehog signaling pathway
He Zhou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Histone Lysine Methylation Dynamics Control EGFR DNA Copy-Number Amplification
Thomas L. Clarke et al.
CANCER DISCOVERY (2020)
SNHG14 stimulates cell autophagy to facilitate cisplatin resistance of colorectal cancer by regulating miR-186/ATG14 axis
Yi Han et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The novel long noncoding RNA CRART16 confers cetuximab resistance in colorectal cancer cells by enhancing ERBB3 expression via miR-371a-5p
Xiaoqian Zhang et al.
CANCER CELL INTERNATIONAL (2020)
Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer
Junshu Li et al.
CARCINOGENESIS (2020)
TSPAN8 promotes colorectal cancer cell growth and migration in LSD1-dependent manner
Hong-Sheng Zhang et al.
LIFE SCIENCES (2020)
Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340
Xiangyu Jian et al.
MOLECULAR CANCER (2020)
Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response
Lin Huan et al.
MOLECULAR CANCER (2020)
Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway
Ye Zhang et al.
AGING-US (2020)
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Andriy Marusyk et al.
CANCER CELL (2020)
Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer
Varun Sasidharan Nair et al.
CLINICAL EPIGENETICS (2020)
Targeting apoptosis in cancer therapy
Benedito A. Carneiro et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells
Alyssa D. Smith et al.
CANCER RESEARCH (2020)
lncRNA UCA1 Contributes to 5-Fluorouracil Resistance of Colorectal Cancer Cells Through miR-23b-3p/ZNF281 Axis
Zhenyu Xian et al.
ONCOTARGETS AND THERAPY (2020)
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li et al.
DRUG RESISTANCE UPDATES (2020)
Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer
Senlin Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin
Qi Wang et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2020)
Combinative treatment of beta-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation
Peng Chen et al.
THERANOSTICS (2020)
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
Jing Sun et al.
ONCOGENE (2019)
LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145
Rongrong Gao et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells
Shuo Huang et al.
CANCER RESEARCH (2019)
被撤回的出版物: miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization (Retracted article. See vol. 16, 2023)
Xiaobin Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
Yanhua Mou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
被撤回的出版物: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer (Retracted article. See vol. 21, 2022)
Tong Liu et al.
MOLECULAR CANCER (2019)
Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
Helai P. Mohammad et al.
NATURE MEDICINE (2019)
The multiple mechanisms that regulate p53 activity and cell fate
Antonina Hafner et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells
Hui Liang et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Long noncoding RNA and mRNA profiling in cetuximab-resistant colorectal cancer cells by RNA sequencing analysis
Changwen Jing et al.
CANCER MEDICINE (2019)
CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer
J. L. Hu et al.
MOLECULAR CANCER (2019)
EGFR is required for Wnt9a-Fzd9b signalling specificity in haematopoietic stem cells
Stephanie Grainger et al.
NATURE CELL BIOLOGY (2019)
Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer
Abdullah Al Emran et al.
EPIGENOMICS (2019)
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
Clemens Zwergel et al.
CLINICAL EPIGENETICS (2019)
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
Srinivas Patnaik et al.
FRONTIERS IN PHARMACOLOGY (2019)
Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil
Tong Liu et al.
NEOPLASIA (2019)
LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors
Shaun Egolf et al.
CELL REPORTS (2019)
LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization
Zhen-xing Liang et al.
CELL DEATH & DISEASE (2019)
Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted Therapy
Alison Hirukawa et al.
CELL REPORTS (2019)
circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637
Yanli Zhang et al.
EBIOMEDICINE (2019)
FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer
Yun-Cheol Chae et al.
NUCLEIC ACIDS RESEARCH (2019)
The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness
Vijayalakshmi Kari et al.
CLINICAL EPIGENETICS (2019)
Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib
Ines De Pauw et al.
CANCERS (2019)
Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer
Liqun Yang et al.
CLINICAL EPIGENETICS (2019)
Histone deacetylase 6 selective inhibitor ACY1215 inhibits cell proliferation and enhances the chemotherapeutic effect of 5-fluorouracil in HCT116 cells
Yuyong Tan et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Phase I clinical trial of decitabine (5-aza-2′-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases
Yanina J. L. Jansen et al.
ESMO OPEN (2019)
Concise update on colorectal cancer epidemiology
Camilla Mattiuzzi et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Dichloroacetate Overcomes Oxaliplatin Chemoresistance in Colorectal Cancer through the miR-543/PTEN/Akt/mTOR Pathway
Yu Liang et al.
JOURNAL OF CANCER (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
miR-146a targets c-met and abolishes colorectal cancer liver metastasis
Anne-Marie Bleau et al.
CANCER LETTERS (2018)
A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53
Chao Mao et al.
CANCER RESEARCH (2018)
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng et al.
CELL (2018)
Epigenetic agents in combined anticancer therapy
Zdenek Kejik et al.
FUTURE MEDICINAL CHEMISTRY (2018)
KDM4B promotes DNA damage response via STAT3 signaling and is a target of CREB in colorectal cancer cells
Wei-Wu Deng et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
KDM6B Counteracts EZH2-Mediated Suppression of IGFBP5 to Confer Resistance to PI3K/AKT Inhibitor Treatment in Breast Cancer
Wenyu Wang et al.
MOLECULAR CANCER THERAPEUTICS (2018)
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
M. R. Migden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment
Elisa Peranzoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19
Jing Ren et al.
THERANOSTICS (2018)
DANRIL promotes chemoresistance via disturbing expression of ABCC1 by regulating the expression of Let-7a in colorectal cancer
Zhen Zhang et al.
BIOSCIENCE REPORTS (2018)
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
Kunihiko Hinohara et al.
CANCER CELL (2018)
Therapy resistance mediated by cancer stem cells
Teresa Bernadette Steinbichler et al.
SEMINARS IN CANCER BIOLOGY (2018)
Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy
Meng Wang et al.
CELL DEATH & DISEASE (2018)
Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis
Mohammed L. Ibrahim et al.
CELL REPORTS (2018)
Therapeutic choices after hypomethylating agent resistance for myelodysplastic syndromes
Guillermo Montalban-Bravo et al.
CURRENT OPINION IN HEMATOLOGY (2018)
(-)-Epigallocatechin-3-gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells
Le Ying et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan
Valerie Lee et al.
CLINICAL CANCER RESEARCH (2018)
Targeting histone methylation for colorectal cancer
Tao Huang et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)
Critical threshold levels of DNA methyltransferase 1 are required to maintain DNA methylation across the genome in human cancer cells
Yi Cai et al.
GENOME RESEARCH (2017)
The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling
Peng Han et al.
MOLECULAR CANCER (2017)
IncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
Yuanyuan Lu et al.
NATURE MEDICINE (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling
Jiong Li et al.
NATURE COMMUNICATIONS (2017)
Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway
Dong Ren et al.
ONCOTARGET (2017)
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat; a phase 2 consortium/stand Up 2 cancer study
Nilofer S. Azad et al.
ONCOTARGET (2017)
STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway
Lin Jin et al.
CANCER RESEARCH (2017)
Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure
Gulfem Dilek Guler et al.
CANCER CELL (2017)
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab
Laura Demurtas et al.
BRITISH JOURNAL OF CANCER (2017)
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance
Brian B. Liau et al.
CELL STEM CELL (2017)
Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α
Yanlei Ma et al.
GUT (2016)
A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma
S. Thomas et al.
ANNALS OF ONCOLOGY (2016)
Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
Elena Ceccacci et al.
BRITISH JOURNAL OF CANCER (2016)
Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription
Pingjiang Ye et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
G9a inhibition potentiates the anti-tumour activity of DNA double-strand break inducing agents by impairing DNA repair independent of p53 status
Pallavi Agarwal et al.
CANCER LETTERS (2016)
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
Silvia Juliana Serrano-Gomez et al.
MOLECULAR CANCER (2016)
Human ATP-Binding Cassette Transporter. ABCG2 Confers Resistance to CUDC-907, a Dual Inhibitor of Histone Deacetylase and Phosphatidylinositol 3-Kinase
Chung-Pu Wu et al.
MOLECULAR PHARMACEUTICS (2016)
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
Maia Vinogradova et al.
NATURE CHEMICAL BIOLOGY (2016)
Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells
Kouji Okada et al.
ONCOLOGY REPORTS (2016)
Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells
Huang Zhijun et al.
TUMOR BIOLOGY (2016)
Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
Michael J. Overman et al.
ONCOTARGET (2016)
Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer
Samer Alzoubi et al.
ONCOTARGET (2016)
EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling
Jian-Fang Chen et al.
ONCOTARGET (2016)
Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients
Salman M. Toor et al.
FRONTIERS IN IMMUNOLOGY (2016)
Effects of Decitabine on Invasion and Exosomal Expression of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells
Shota Tanaka et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjects
Lan-Xiang Wu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine
Edward M. Newman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
David Roulois et al.
CELL (2015)
HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF-Mutant Colorectal Cancer by Downregulation of c-FLIPL
Robbie Carson et al.
CLINICAL CANCER RESEARCH (2015)
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Yoshinaga Okugawa et al.
GASTROENTEROLOGY (2015)
MicroRNA-520g Confers Drug Resistance by Regulating p21 Expression in Colorectal Cancer
Yang Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth
Alessia Peserico et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts
Jean Albrengues et al.
NATURE COMMUNICATIONS (2015)
Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3
Baolai Zhang et al.
ONCOTARGET (2015)
DZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis
Mingquan Sha et al.
ACTA PHARMACEUTICA SINICA B (2015)
New Insights on the Mechanism of Quinoline-based DNA Methyltransferase Inhibitors
Christina Gros et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer
Jose A. Galvan et al.
ONCOTARGET (2015)
The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis
Clara Dees et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells
Bryson W. Katona et al.
CANCER BIOLOGY & THERAPY (2014)
Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: Underlying molecular mechanisms
Mohamed-Salah I. Abaza et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer
Catia Moutinho et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia
Stephan Emmrich et al.
MOLECULAR CANCER (2014)
DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells
Sylwia Flis et al.
PLOS ONE (2014)
Combination of Gefitinib and DNA Methylation Inhibitor Decitabine Exerts Synergistic Anti-Cancer Activity in Colon Cancer Cells
Yun-feng Lou et al.
PLOS ONE (2014)
Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation
K. A. Kang et al.
CELL DEATH & DISEASE (2014)
LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers
Haiyang Yu et al.
NATURE COMMUNICATIONS (2014)
Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer
Akari Hashimoto et al.
CASE REPORTS IN ONCOLOGY (2014)
BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production
Yunha Kim et al.
AUTOPHAGY (2013)
Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy
Reda Z. Mahfouz et al.
CLINICAL CANCER RESEARCH (2013)
A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer
I. Garrido-Laguna et al.
INVESTIGATIONAL NEW DRUGS (2013)
Molecular Modeling Studies of the Novel Inhibitors of DNA Methyltransferases SGI-1027 and CBC12: Implications for the Mechanism of Inhibition of DNMTs
Jakyung Yoo et al.
PLOS ONE (2013)
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
Alberto Bardelli et al.
CANCER DISCOVERY (2013)
MicroRNA-10b is a Prognostic Indicator in Colorectal Cancer and Confers Resistance to the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cells
Naohiro Nishida et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models
Young-Soon Na et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer
H. Zhang et al.
CELL DEATH AND DIFFERENTIATION (2011)
BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma
Christopher S. Williams et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Autophagy as a target for anticancer therapy
Filip Janku et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
Kimio Yonesaka et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
MicroRNA-451 Is Involved in the Self-renewal, Tumorigenicity, and Chemoresistance of Colorectal Cancer Stem Cells
Nerea Bitarte et al.
STEM CELLS (2011)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-XL in colorectal cancer cells
Haruo Nakano et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Convergence between Wnt-β-catenin and EGFR signaling in cancer
Tianhui Hu et al.
MOLECULAR CANCER (2010)
A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells
Li Lin et al.
MOLECULAR CANCER (2010)
Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors
Ruth Plummer et al.
CLINICAL CANCER RESEARCH (2009)
Valproic acid enhances bosutinib cytotoxicity in colon cancer cells
Luca Mologni et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
Robert P. Whitehead et al.
INVESTIGATIONAL NEW DRUGS (2009)
Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells
Kenneth K. W. To et al.
MOLECULAR CANCER RESEARCH (2008)
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors
Kim Appleton et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo
Anthony Tumber et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors:: A clinical and translational study
Pamela Muenster et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Effect of combined therapy with low-dose 5-aza-2′-deoxycytidine and irinotecan on colon cancer cell line HCT-15
Megumi Ishiguro et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Hydralazine target:: From blood vessels to the epigenome
C Arce et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases
B Brueckner et al.
CANCER RESEARCH (2005)
Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells
J Schauber et al.
MOLECULAR IMMUNOLOGY (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Disulfiram-mediated inhibition of NF-κB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines
WG Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma
I Petak et al.
CELL DEATH AND DIFFERENTIATION (2003)
Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer
JMD Wheeler et al.
GUT (2001)
分享论文
